CAH

Cardinal Health, Inc. · NYSE · Healthcare · USD · 10-K for 2026, filed 2026-08-11

Figures on this page computed 2026-11-08 12:06 UTC

Last close

271.72USD

Market data, 2026-11-06

Except where said otherwise: 10-K for 2026, filed 2026-08-11

  • 37.4xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2026
    Accession
    0000721371-26-000038
    Reported in
    USD
    • computed
    • 10-K for 2026, filed 2026-08-11

    The filing itself

  • 85.6%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2026
    Accession
    0000721371-26-000038
    Reported in
    USD
    • 10-K for 2026, filed 2026-08-11
    • 10-K for 2026, filed 2026-08-11
    • 10-K for 2026, filed 2026-08-11
    • 10-K for 2026, filed 2026-08-11
    • 10-K for 2026, filed 2026-08-11
    • 10-K for 2026, filed 2026-08-11

    The filing itself

  • 0.7%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0000721371-26-000038
    Reported in
    USD
    • 10-K for 2026, filed 2026-08-11
    • 10-K for 2026, filed 2026-08-11

    The filing itself

  • 1.8%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0000721371-26-000038
    Reported in
    USD
    • 10-K for 2026, filed 2026-08-11
    • 10-K for 2026, filed 2026-08-11

    The filing itself

  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2026
    Accession
    0000721371-26-000038
    Reported in
    USD
    • 10-K for 2026, filed 2026-08-11
    • 10-K for 2026, filed 2026-08-11

    The filing itself

  • 0.8%Dividend yield
    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed
    • computed
    • computed
    • computed
    • computed
    • Computed from the filing for 2026, filed 2026-08-11

What it sells, to whom

lens 8 of 9

What it sells

3
Pharmaceutical and Specialty Solutions234,833,000,000 USD92.3%
GMPD12,719,000,000 USD5%
Other Operating Segment6,792,000,000 USD2.7%

Where it sells it

2
UNITED STATES252,639,000,000 USD99.3%
Non-US1,705,000,000 USD0.7%

Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.

3 segments, 2 places and 0 named customers, each as the filer published it.

3 segments, 2 places and 0 named customers, each as the filer published it.

Every figure in this lens

Except where said otherwise: 10-K for 2026, filed 2026-08-11

  • Pharmaceutical and Specialty Solutions234,833,000,000
    Source
    filed
    Statement
    segments
    Fiscal year
    2026
    Accession
    0000721371-26-000038
    Reported in
    USD

    The filing itself

  • GMPD12,719,000,000
    Source
    filed
    Statement
    segments
    Fiscal year
    2026
    Accession
    0000721371-26-000038
    Reported in
    USD

    The filing itself

  • Other Operating Segment6,792,000,000
    Source
    filed
    Statement
    segments
    Fiscal year
    2026
    Accession
    0000721371-26-000038
    Reported in
    USD

    The filing itself

  • UNITED STATES252,639,000,000
    Source
    filed
    Statement
    revenue_mix
    Fiscal year
    2026
    Accession
    0000721371-26-000038
    Reported in
    USD

    The filing itself

  • Non-US1,705,000,000
    Source
    filed
    Statement
    revenue_mix
    Fiscal year
    2026
    Accession
    0000721371-26-000038
    Reported in
    USD

    The filing itself

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.